It was a busy week for the biotech sector, with lots of regulatory and pipeline updates amid fears of a global recession ...

Pacira settles Exparel patent cases, grants Fresenius phased license for generic sales beginning in 2030, with full access no ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...

Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a ...